CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer.
Cytomx Therapeutics stock last closed at $0.80, down 3.63% from the previous day, and has decreased 46.58% in one year. It has underperformed other stocks in the Biotechnology industry by 0.14 percentage points. Cytomx Therapeutics stock is currently +6.13% from its 52-week low of $0.75, and -86.39% from its 52-week high of $5.85.
There are currently 78.26M CTMX shares outstanding. The market cap of CTMX is $62.29M. In the last 24 hours, 862,486 CTMX shares were traded.
How to Buy Cytomx Therapeutics Stock
Not sure how to invest in Cytomx Therapeutics stock? Here's how.
Choose where to buy Cytomx Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Cytomx Therapeutics stock.
Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit funds into your brokerage account: Choose your payment method and add your information.
Analyze Cytomx Therapeutics stock: The Cytomx Therapeutics ticker symbol is CTMX. Is Cytomx Therapeutics stock a good investment? Should you buy shares of CTMX? How do CTMX's underlying business fundamentals look? Do top analysts think Cytomx Therapeutics is a good buy? Why has CTMX's stock price moved recently? (Hint: Our stock market research website can help you figure out if CTMX is a good stock to buy).
Make your CTMX buy order: Decide if you will purchase CTMX shares at the current market price or use a limit order to purchase CTMX stock at a particular price.
Get notifications regarding your CTMX investment: Create a watchlist to keep tabs on your position in Cytomx Therapeutics shares.
Step 1: Choose where to buy Cytomx Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy CTMX stock.
A brokerage account is an investment account that enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to world financial markets: From Tech to Energy, New York to Tokyo — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've picked your brokerage, you need to fill out some personal info so you can buy CTMX today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Cytomx Therapeutics stock
After you have selected the best place to buy Cytomx Therapeutics stock, it's very important to evaluate their stock before you invest, so you actually comprehend the risk and upside.
Cytomx Therapeutics shares quick numbers
CTMX Price
$0.80
1w %
-5.24%
1y %
-46.58%
5y %
-88.84%
P/E
4.68x
P/B
-2.66x
P/S
0.53x
PEG
N/A
Revenue
$126.62M
Earnings
$13.83M
Fore. Rev. Growth
-18.63%
Fore. Earn. Growth
N/A
Market Cap
$62.29M
Next Earnings
Mar 10, 2025
Next Dividend
N/A
Fundamentals of Cytomx Therapeutics
WallStreetZen was created to help average investors perform more in-depth fundamental analysis.
Last year, CTMX revenue was $126.62M. During the past five year, CTMX's revenue has gone up by 15.85% per year. This was slower than the Biotechnology industry average of 59.48%.
No, Cytomx Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about CTMX
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your CTMX buy order
There are two main options:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are mostly the best for newer investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a given dollar amount limit, use a limit order.
Press the Open button and your broker will place the order.
If you require more help with investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Cytomx Therapeutics share?
As of Feb 14, 2025, it costs $0.80 to buy one share of Cytomx Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.4, you can buy 0.5 shares of CTMX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.